Latest Articles
Algorithms 'more likely to suppress women's health content over men's' - The Southern Reporter
Algorithms 'more likely to suppress women's health content over men's' The Southern Reporter
Published: July 14, 2025, 12:45 p.m.
Algorithms 'more likely to suppress women's health content over men's' - The Scotsman
Algorithms 'more likely to suppress women's health content over men's' The Scotsman
Published: July 14, 2025, 12:45 p.m.
(PDF) Expression analysis of plasma extracellular vesicle associated candidate MiRNAs in endometriosis using integrative bioinformatics and experiential data - researchgate.net
(PDF) Expression analysis of plasma extracellular vesicle associated candidate MiRNAs in endometriosis using integrative bioinformatics and experiential data researchgate.net
Published: July 14, 2025, 4:24 a.m.
ICMR to roll out multidisciplinary care model for gynaec disorder - The New Indian Express
ICMR to roll out multidisciplinary care model for gynaec disorder The New Indian Express
Published: July 14, 2025, 3:01 a.m.
Olivia Culpo shares first photos of newborn daughter with Christian McCaffrey - The Express Tribune
Olivia Culpo shares first photos of newborn daughter with Christian McCaffrey The Express Tribune
Published: July 13, 2025, 11:35 p.m.
From pain to prevention, endometriosis treatment is finally offering relief | Mint - Mint
From pain to prevention, endometriosis treatment is finally offering relief | Mint Mint
Published: July 13, 2025, 9:30 a.m.
Kadriye Baskurt: Grateful to Have Joined the ESMO Endometrial Cancer Preceptorship in Lugano - Oncodaily
Kadriye Baskurt: Grateful to Have Joined the ESMO Endometrial Cancer Preceptorship in Lugano Oncodaily
Published: July 12, 2025, 8 p.m.
Dostarlimab Plus Chemo Prolongs Time to First, Second Subsequent Therapy Regardless of Age in Endometrial Cancer - OncLive
Dostarlimab Plus Chemo Prolongs Time to First, Second Subsequent Therapy Regardless of Age in Endometrial Cancer OncLive
Published: July 11, 2025, 6:17 p.m.
BioNTech’s Promising Phase III Trial for Recurrent Endometrial Cancer - TipRanks
BioNTech’s Promising Phase III Trial for Recurrent Endometrial Cancer TipRanks
Published: July 11, 2025, 4:24 p.m.
Study finds pregnancy risks higher with ART in kidney transplant recipients - Contemporary OB/GYN
Study finds pregnancy risks higher with ART in kidney transplant recipients Contemporary OB/GYN
Published: July 11, 2025, 3:25 p.m.
Link copied to clipboard!